Rapid depletion of “catch-and-release” anti-ASGR1 antibody in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapid depletion of “catch-and-release” anti-ASGR1 antibody in vivo

Published:2024-07-25 Issue:1 Volume:16 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Devanaboyina Siva Charan¹^ORCID,Li Peng²,LaGory Edward L.¹,Poon-Andersen Carrie¹,Cook Kevin D.¹,Soto Marcus³,Wang Zhe¹,Dang Khue²,Uyeda Craig¹,Case Ryan B.⁴,Thomas Veena A.¹,Primack Ronya³,Ponce Manuel³,Di Mei⁵,Ouyang Brian²,Kaner Joelle²,Lam Sheung Kwan²,Mostafavi Mina²

Affiliation:

1. Department of Pharmacokinetics and Drug Metabolism, Amgen Research, Amgen Inc, South San Francisco, CA, USA

2. Department of Biologics, Amgen Research, Amgen Inc, South San Francisco, CA, USA

3. Department of Pharmacokinetics and Drug Metabolism, Amgen Research, Amgen Inc, Thousand Oaks, CA, USA

4. Department of Lead Discovery and Characterization, Amgen Research, Amgen Inc, South San Francisco, CA, USA

5. Department of Cardiometabolic disorders, Amgen Research, Amgen Inc, South San Francisco, CA, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2024.2383013

Reference58 articles.

1. Continuous cultures of fused cells secreting antibody of predefined specificity

2. Designing antibodies as therapeutics

3. Antibodies to watch in 2023

4. FcRn: the neonatal Fc receptor comes of age

5. Pharmacokinetics of Monoclonal Antibodies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP